Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Consumer services    tags : Phase 2    save search

Melco unveils thrilling all-weather indoor waterpark and Epic Tower at Studio City Phase 2
Published: 2023-04-06 (Crawled : 11:00) - globenewswire.com
MLCO | $6.155 -1.2% -1.22% 2.5M twitter stocktwits trandingview |
Consumer Services
| | O: 1.21% H: 1.36% C: 0.8%

city phase 2
Marker Therapeutics Awarded $2 Million Grant from U.S. FDA to Support Marker’s Phase 2 ARTEMIS Trial of MT-401
Published: 2022-09-13 (Crawled : 13:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K twitter stocktwits trandingview |
Consumer Services
| | O: 6.47% H: 4.61% C: 0.61%

mt-401 fda artemis grant trial therapeutics phase 2
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K twitter stocktwits trandingview |
Consumer Services
| | O: 2.29% H: 2.41% C: -5.17%

phase 2 aml
Studio City Phase 2 wins BREEAM Awards 2021 regional accolade
Published: 2021-04-09 (Crawled : 11:00) - globenewswire.com
MLCO | $6.155 -1.2% -1.22% 2.5M twitter stocktwits trandingview |
Consumer Services
| | O: -2.49% H: 2.5% C: 1.5%

phase 2 awards
Marker Therapeutics Announces Dosing of First Patient in Phase 2 Trial of MT-401 in Acute Myeloid Leukemia Following Stem Cell Transplant
Published: 2021-03-03 (Crawled : 19:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K twitter stocktwits trandingview |
Consumer Services
| | O: 3.2% H: 4.26% C: 0.39%

phase 2 myeloid leukemia stem cell leukemia trial acute myeloid leukemia
Studio City Phase 2 shortlisted for BREEAM Awards 2021
Published: 2021-01-28 (Crawled : 09:00) - globenewswire.com
MLCO | $6.155 -1.2% -1.22% 2.5M twitter stocktwits trandingview |
Consumer Services
| | O: -0.58% H: 4.68% C: 3.57%

phase 2 awards
Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical Trial
Published: 2021-01-05 (Crawled : 15:00) - biospace.com/
MRKR | $4.25 3.65% 3.52% 15K twitter stocktwits trandingview |
Consumer Services
| | O: 18.37% H: 25.86% C: -0.57%

fda trial phase 2 clinical hold aml
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.